Anti-recurrent Immunocorrection in Gynecology Andrology and Proctology
article
OA: diamond
CC0
⤵ 3 in-corpus citations
Abstract
The article provides evidence of clinical experience with the use of Arecur® for the treatment of endocervicitis and dysplasia of the cervix, endometrioma, chronic bacterial prostatitis, and for postoperative rehabilitation in patients after removal of hemorrhoids. Arecur® contains exogenous peptides of natural origin – anti-infective proteins of the group of defensins and RJP-1 and has antibacterial, antiviral, anti-inflammatory and antitumor activity. In the study groups, in which Arecur® was assigned to the patients, were reported significantly better clinical efficacy results. The ability of exogenous peptides to mobilize T-lymphocytes to identify and destroy infected and atypical cells determines the elimination of human papilloma virus and creates the conditions for reducing the risk of malignant cell transformation of cervical canal. Arecur®, by enhancing the immune supervision of ectopic endometrial cells, promotes regression of clinical symptoms and prolongation of inter-relapsing intervals in patients with endometriosis. In chronic bacterial prostatitis Arecur® increases the efficiency of etiotropic and symptomatic therapy. After surgical removal of hemorrhoid lesions, Arecur® provides more positive dynamics of rehabilitation, improves patients' quality of life and prevents complications. The obtained results allow us to reasonably recommend Arecur® as a medicine for anti-recurrent immunocorrection in gynecology, andrology and proctology.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- The endometrial immune environment of women with endometriosis 2019
- Role of Endometrial Autophagy in Physiological and Pathophysiological Processes 2019
- Roles of Regulatory T Cells in Pathogenesis of Endometriosis 2019
- A new look at endometriosis: the role of restoring of full immune surveillance over ectopic cells of the endometrium 2017
Cited by (3)
- Prospects for the Treatment of Endometriosis: The Effect of Immune Peptides on the Reactivation of Immune Surveillance over Ectopic Endometrial Cells 2020
- Quality of life of endometriosis patients: focus on pain syndrome and neurological disorders 2025
- ETIOPATHOGENETIC JUSTIFICATION OF ENDOMETRIOSIS IMMUNOTHERAPY 2025
References (12)
- A new look at endometriosis: the role of restoring of full immune surveillance over ectopic cells of the endometrium via openalex
- Role of Endometrial Autophagy in Physiological and Pathophysiological Processes via openalex
- Roles of Regulatory T Cells in Pathogenesis of Endometriosis via openalex
- The endometrial immune environment of women with endometriosis via openalex
- W2926238016 via openalex
- W2965924609 via openalex
- W3093886855 via openalex
- W2057696719 via openalex
- W4321374662 via openalex
- W2123085223 via openalex
- W2263234443 via openalex
- W2791977325 via openalex
Cited by (3)
- Quality of life of endometriosis patients: focus on pain syndrome and neurological disorders 2025
- ETIOPATHOGENETIC JUSTIFICATION OF ENDOMETRIOSIS IMMUNOTHERAPY 2025
- Prospects for the Treatment of Endometriosis: The Effect of Immune Peptides on the Reactivation of Immune Surveillance over Ectopic Endometrial Cells 2020
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK